Sigma-Aldrich Corporation (SIAL) declared that its Research business unit has entered into an alliance with Vlaams Instituut voor Biotechnologie (“VIB”), a leading life science research institute based in Flanders, Belgium, to enhance the commercialization and supply of research tools. This will provide translational researchers with faster access to novel tools and technologies required for research.
This collaboration between the two companies will be beneficial as it will address the challenges that scientists face during their research, by providing advanced research tools and technologies. This joint venture is also looking forward to utilize Sigma-Aldrich’s, research and development expertise, its manufacturing units and wide supply chain network, to speed up the commercialization and availability of VIB's research tools and technologies. This will result in the efficient use of resources and help further scientific discoveries.
Through this deal, Sigma-Aldrich strives to support the requirements of researchers and address the concerns of research reproducibility. This is the second collaboration made by Sigma-Aldrich for accelerating the commercialization of research reagents with VIB after a recent agreement with Scripps Research Institute on the same goal.
Sigma-Aldrich’s Research business unit is a global leader in supporting translational researchers by supplying products, services and solutions required to facilitate scientific discoveries. Thus, this venture will help further ground-breaking discoveries through the development of tools and technologies that solve many contemporary research questions.
Sigma-Aldrich is among the prominent specialty chemicals companies along with Globe Specialty Metals, Inc. (GSM), Minerals Technologies Inc. (MTX) and Ashland Inc. (ASH).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment